First Trust NYSE Arca Biotechnology Index Fund
127 hedge funds and large institutions have $2.04B invested in First Trust NYSE Arca Biotechnology Index Fund in 2015 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 53 increasing their positions, 40 reducing their positions, and 20 closing their positions.
192% more call options, than puts
Call options by funds: $6.47M | Put options by funds: $2.22M
184% more capital inflows, than outflows
Capital inflows: $298M | Capital outflows: $105M
33% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 40
10% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 20
1% more funds holding
Funds holding: 126 → 127 (+1)
33% less funds holding in top 10
Funds holding in top 10: 12 → 8 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
+$194M |
| 2 |
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$25.6M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$11M |
| 4 |
Tower Research Capital (TRC)
New York
|
+$9.36M |
| 5 |
Transamerica Financial Advisors
St. Petersburg,
Florida
|
+$8.64M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$22.2M |
| 2 |
Goldman Sachs
New York
|
-$11.2M |
| 3 |
Morgan Stanley
New York
|
-$7.28M |
| 4 |
Keel Point
Huntsville,
Alabama
|
-$7.18M |
| 5 |
NCM
Niemann Capital Management
Stateline,
Nevada
|
-$6.62M |
FBT Hedge Fund Activity: Q3 2015 in Review
127 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q3 2015, worth a combined $2.04B — down 11% from $2.29B a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new FBT positions and 20 closed out — a net gain of 2 holders — while 53 added to existing stakes and 40 trimmed.
The largest buyer was First Trust Advisors, adding an estimated $194M. The largest seller was Wells Fargo, cutting an estimated $22.2M.
- 127 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q3 2015, up from 126 in Q2 2015.
- Funds reported $2.04B of First Trust NYSE Arca Biotechnology Index Fund stock for Q3 2015, down 11% quarter-over-quarter.
- 22 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q3 2015 and 20 closed out, a net change of +2 holders.
- The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q3 2015 was First Trust Advisors, an estimated $194M added.
- The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q3 2015 was Wells Fargo, an estimated $22.2M sold.
Based on aggregated 13F filings for Q3 2015.